Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_41933 | 519 | 10.82 | Mlig455_034108 | Neo: - Age: Down-Down-Up |
Mlig455_034108 {REF} {Length: 2442} {RNA1509_22399} {RNA1310_1594.1} {RNA815_19978} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 2.041 | 3.63 | 0.04763 | 0.51918 | |
RegionR2 | 0.698 | 3.63 | 0.14166 | 0.46833 | |
RegionR3 | -0.86 | 3.63 | 0.03056 | 0.30085 | |
RegionR4 | -0.592 | 3.63 | 0.23641 | 0.53117 | |
RegionR5 | -1.176 | 3.63 | 0.00120 | 0.01177 | |
RegionR6 | -0.52 | 3.63 | 0.19379 | 0.76111 | |
RegionR7 | -0.316 | 3.63 | 0.59253 | 1.00000 | |
RegionR8 | 0.724 | 3.63 | 0.28156 | 0.90800 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.696 | 3.63 | 0.21392 | 0.95150 | |
RegenerationR2 | 0.372 | 3.63 | 0.28706 | 0.72976 | |
RegenerationR3 | 0.15 | 3.63 | 0.74852 | 0.96417 | |
RegenerationR4 | -0.237 | 3.63 | 0.61209 | 0.91784 | |
RegenerationR5 | -0.215 | 3.63 | 0.62149 | 0.91932 | |
RegenerationR6 | -0.301 | 3.63 | 0.52262 | 0.82220 | |
RegenerationBL | -0.939 | 3.63 | 0.14633 | 0.45676 | |
RegenerationTP | -0.748 | 3.63 | 0.24808 | 0.69541 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_41933 | 519 | 10.82 | Mlig455_034108 | Neo: - Age: Down-Down-Up |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_034108 {REF} {Length: 2442} {RNA1509_22399} {RNA1310_1594.1} {RNA815_19978} | |
2. | MligTC455_53842 | 1222 | 25.46 | Mlig455_023890 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.345 Region-enriched R2: 1.546/0.01667 |
3.384 | 0.784 | - | - | 0.957 | 0.882 | 0.761 | Mlig455_023890 {REF} {Length: 1336} {RNA1509_15580} {RNA1310_22487.1} {RNA815_10676.1} | |
3. | MligTC455_53844 | 1403 | 29.24 | Mlig455_051626 | Neo: - |
3.374 | 0.759 | - | - | 0.836 | 0.960 | 0.819 | Mlig455_051626 {REF} {Length: 1671} {RNA1509_15580} {RNA1310_24090} {RNA815_10676.2} | |
4. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 3.156 | 0.703 | - | - | 0.763 | 0.960 | 0.730 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
5. | MligTC455_49579 | 654 | 13.62 | Mlig455_042523 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.646 Region-enriched R2: 1.286/0.04858 |
ANO7 | 2.73 | - | - | - | 0.882 | 0.974 | 0.874 | Mlig455_042523 {REF} {Length: 4425} {Pfam: Calcium-activated chloride channel [PF04547.14, score=254.3]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=23.0]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=118, Expect=3e-26]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=124, Expect=4e-28]} {Dmel: FBgn0030349, CG10353, [Score=119, Expect=7e-27]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=161, Expect=4e-40]} {Smed: dd_Smed_v6_6514_0_4, dd_Smed_v6_6514_0_4, [Score=127, Expect=2e-29]} {RNA1509_21269} {RNA1310_4099.1} {RNA815_1067} |
6. | MligTC455_23584 | 574 | 11.95 | Mlig455_050813 | Neo: - |
CCDC33 | 2.723 | - | - | - | 0.952 | 0.847 | 0.924 | Mlig455_050813 {REF} {Length: 3399} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=24.3]; C-terminal membrane-localisation domain of ion-channel, VCN1 [PF16799.7, score=19.4]} {Human: ENSG00000140481, CCDC33, coiled-coil domain containing 33, [RH, Score=94.4, Expect=4e-19]} {Mouse: ENSMUSG00000037716, Ccdc33, coiled-coil domain containing 33, [Score=145, Expect=4e-35]} {Smed: dd_Smed_v6_15844_0_1, dd_Smed_v6_15844_0_1, [RH, Score=191, Expect=6e-50]} {RNA1509_7141} {RNA1310_15581.1} {RNA815_780.1} |
7. | MligTC455_49578 | 920 | 19.17 | Mlig455_042519 | Neo: - Age: logFC(26M/2M)=-0.236 Region-enriched R2: 1.433/0.00873 |
ANO7 | 2.695 | - | - | - | 0.892 | 0.961 | 0.842 | Mlig455_042519 {REF} {Length: 3579} {Pfam: Calcium-activated chloride channel [PF04547.14, score=222.4]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=30.6]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=114, Expect=3e-25]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=120, Expect=3e-27]} {Dmel: FBgn0038721, subdued, [Score=117, Expect=2e-26]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=161, Expect=1e-40]} {Smed: dd_Smed_v6_6514_0_4, dd_Smed_v6_6514_0_4, [Score=126, Expect=2e-29]} {RNA1509_19842, RNA1509_21022, RNA1509_21269} {RNA1310_4099.1, RNA1509_19842, RNA1509_21022} {RNA1509_19842, RNA1509_21022, RNA815_1067} |
8. | MligTC455_35942 | 1134 | 23.63 | Mlig455_048067 | Neo: - Age: logFC(26M/2M)=-0.435 |
DCDC2C | 2.682 | - | - | - | 0.873 | 0.956 | 0.853 | Mlig455_048067 {REF} {Length: 3258} {Pfam: Doublecortin [PF03607.19, score=93.4]} {Human: ENSG00000214866, DCDC2C, doublecortin domain containing 2C, [RH, Score=100, Expect=7e-23]; ENSG00000146038, DCDC2, doublecortin domain containing 2, [RH, Score=100, Expect=3e-22]} {Mouse: ENSMUSG00000035910, Dcdc2a, doublecortin domain containing 2a, [RH, Score=105, Expect=2e-24]} {Celegans: WBGene00007374, C06C3.3, [RH, Score=52.4, Expect=4e-07]} {Smed: dd_Smed_v6_20159_0_1, dd_Smed_v6_20159_0_1, [RH, Score=187, Expect=9e-55]} {RNA1509_40680} {RNA1310_11042} {RNA815_6202} |
9. | MligTC455_13945 | 222 | 4.62 | Mlig455_008055 | Neo: - Age: logFC(26M/2M)=-0.728 |
SYT14 | 2.655 | - | - | - | 0.959 | 0.803 | 0.893 | Mlig455_008055 {REF} {Length: 3788} {Pfam: C2 domain [PF00168.32, score=38.0]} {Human: ENSG00000143469, SYT14, synaptotagmin 14, [Score=133, Expect=5e-32]; ENSG00000139973, SYT16, synaptotagmin 16, [Score=129, Expect=2e-30]} {Mouse: ENSMUSG00000016200, Syt14, synaptotagmin XIV, [Score=134, Expect=7e-32]} {Dmel: FBgn0261086, Syt14, Synaptotagmin 14, [Score=109, Expect=2e-24]} {Smed: dd_Smed_v6_9548_0_2, dd_Smed_v6_9548_0_2, [Score=137, Expect=2e-34]} {RNA1509_12459} {RNA1310_670.1, RNA1509_12459} {RNA1509_12459, RNA815_9293} |
10. | MligTC455_32445 | 285 | 5.93 | Mlig455_041727, Mlig455_042282 | Neo: - Age: - |
ANK2 | 2.613 | - | - | - | 0.908 | 0.964 | 0.741 | Mlig455_041727 {REF} {Length: 4931} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.7]; Ankyrin repeats (many copies) [PF13637.8, score=238.3]; Ankyrin repeat [PF00023.32, score=223.0]; Ankyrin repeats (many copies) [PF13857.8, score=214.9]; Ankyrin repeat [PF13606.8, score=201.4]; Ion transport protein [PF00520.33, score=46.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=211, Expect=1e-54]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=290, Expect=2e-80]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=210, Expect=2e-54]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=489, Expect=7e-151]} {Smed: dd_Smed_v6_6201_0_2, dd_Smed_v6_6201_0_2, [RH, Score=745, Expect=0.0]} {RNA1509_18945} {RNA1310_1506.1, RNA1509_18945} {RNA1509_18945, RNA815_450.1} Mlig455_042282 {REF} {Length: 4940} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=273.8]; Ankyrin repeats (many copies) [PF13637.8, score=232.4]; Ankyrin repeat [PF00023.32, score=218.4]; Ankyrin repeats (many copies) [PF13857.8, score=210.6]; Ankyrin repeat [PF13606.8, score=197.5]; Ion transport protein [PF00520.33, score=46.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=214, Expect=2e-55]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=204, Expect=1e-52]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=201, Expect=2e-51]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=205, Expect=6e-53]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=487, Expect=5e-150]} {Smed: dd_Smed_v6_6201_0_2, dd_Smed_v6_6201_0_2, [RH, Score=736, Expect=0.0]} {RNA1509_18945} {RNA1310_1506.1} {RNA815_8298} |
11. | MligTC455_38368 | 107 | 2.24 | Mlig455_026435, Mlig455_044757 | Neo: - Age: Up-Down-Down |
SSUH2 | 2.604 | - | - | - | 0.914 | 0.955 | 0.735 | Mlig455_026435 {REF} {Length: 1789} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [RH, Score=233, Expect=1e-72]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [RH, Score=195, Expect=1e-58]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=117, Expect=3e-29]} {RNA1509_6425} {RNA1310_32434} {RNA815_16161} Mlig455_044757 {REF} {Length: 883} {TRANSSPLICED} {RNA1509_28356} {RNA1310_61125} {RNA815_53103} |
12. | MligTC455_19338 | 2431 | 50.65 | Mlig455_022165 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.390 Region-specific R2: 3.133 Region-enriched R2: 2.312/0.00036 |
2.581 | - | - | - | 0.876 | 0.967 | 0.738 | Mlig455_022165 {REF} {Length: 1038} {RNA1509_18606, RNA1509_6523} {RNA1310_50737, RNA1509_18606, RNA1509_6523} {RNA1509_18606, RNA1509_6523, RNA815_26880} | |
13. | MligTC455_25589 | 1419 | 29.55 | Mlig455_029945 | Neo: - Age: - Region-enriched R2: 2.293/0.00000 Regeneration-downregulated BL: -3.516 Regeneration-depleted BL: -3.516 |
2.581 | - | - | - | 0.851 | 0.951 | 0.779 | Mlig455_029945 {REF} {Length: 1261} {Pfam: Helix-turn-helix domain [PF12645.9, score=19.8]; Domain of unknown function (DUF1848) [PF08902.13, score=19.3]} {RNA1509_17753} {RNA1310_70608, RNA1509_17753} {RNA1509_17753, RNA815_1498.1} | |
14. | MligTC455_27988 | 1036 | 21.59 | Mlig455_006811, Mlig455_055192 | Neo: - |
CFAP54 | 2.571 | - | - | - | 0.983 | 0.872 | 0.716 | Mlig455_006811 {REF} {Length: 11171} {Pfam: Cilia- and flagella-associated protein 54 [PF14858.8, score=586.0]} {Human: ENSG00000188596, CFAP54, cilia and flagella associated protein 54, [RH, Score=1136, Expect=0.0]} {Mouse: ENSMUSG00000020014, Cfap54, cilia and flagella associated protein 54, [Score=1144, Expect=0.0]} {Smed: dd_Smed_v6_9860_0_1, dd_Smed_v6_9860_0_1, [Score=347, Expect=2e-95]} {RNA1509_2904} {RNA1310_96.1} {RNA815_135} Mlig455_055192 {REF} {Length: 10890} {Pfam: Cilia- and flagella-associated protein 54 [PF14858.8, score=578.4]} {Human: ENSG00000188596, CFAP54, cilia and flagella associated protein 54, [Score=1112, Expect=0.0]} {Mouse: ENSMUSG00000020014, Cfap54, cilia and flagella associated protein 54, [RH, Score=1114, Expect=0.0]} {Smed: dd_Smed_v6_9860_0_2, dd_Smed_v6_9860_0_2, [RH, Score=519, Expect=1e-147]} {RNA1509_2904} {RNA1310_96.1} {RNA815_135} |
15. | MligTC455_35259 | 2265 | 47.19 | Mlig455_040978 | Neo: - Age: Up-Down-Down Region-specific R2: 2.606 Region-enriched R2: 1.588/0.00387 |
ADGRL2 | 2.549 | - | - | - | 0.860 | 0.982 | 0.707 | Mlig455_040978 {REF} {Length: 10808} {TRANSSPLICED} {Pfam: PDZ domain [PF00595.26, score=86.9]; 7 transmembrane receptor (Secretin family) [PF00002.26, score=76.2]; PDZ domain [PF17820.3, score=67.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=52.3]; PDZ domain [PF13180.8, score=36.4]; ZU5 domain [PF00791.22, score=30.8]; Guanylate kinase [PF00625.23, score=22.4]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=174, Expect=1e-42]} {Mouse: ENSMUSG00000034917, Tjp3, tight junction protein 3, [RH, Score=172, Expect=9e-43]} {Dmel: FBgn0262614, pyd, polychaetoid, [RH, Score=232, Expect=8e-61]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=174, Expect=4e-43]} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [RH, Score=833, Expect=0.0]} {RNA1509_17602, RNA1509_52679, RNA1509_58629} {RNA1310_236.2, RNA1509_17602, RNA1509_58629} {RNA1509_17602, RNA1509_58629, RNA815_77.1} |
16. | MligTC455_42840 | 147 | 3.06 | Mlig455_003645 | Neo: - Age: - |
2.546 | - | - | - | 0.822 | 0.978 | 0.746 | Mlig455_003645 {REF} {Length: 1270} {RNA1509_48973} {RNA1310_36721} {RNA815_36286} | |
17. | MligTC455_42625 | 514 | 10.71 | Mlig455_030550 | Neo: - Age: logFC(26M/2M)=-0.257 |
FHAD1 | 2.525 | - | - | - | 0.828 | 0.966 | 0.731 | Mlig455_030550 {REF} {Length: 4380} {TRANSSPLICED} {Pfam: FHA domain [PF00498.28, score=46.8]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=28.5]} {Human: ENSG00000142621, FHAD1, forkhead associated phosphopeptide binding domain 1, [Score=94.0, Expect=1e-18]} {Mouse: ENSMUSG00000051435, Fhad1, forkhead-associated (FHA) phosphopeptide binding domain 1, [Score=89.4, Expect=2e-17]; ENSMUSG00000116181, Fhad1, forkhead-associated (FHA) phosphopeptide binding domain 1, [Score=89.4, Expect=2e-17]} {Smed: dd_Smed_v6_14350_0_1, dd_Smed_v6_14350_0_1, [Score=122, Expect=1e-27]} {RNA1509_16296, RNA1509_55326} {RNA1310_9155.1, RNA1509_16296, RNA1509_55326} {RNA1509_16296, RNA1509_55326, RNA815_22370} |
18. | MligTC455_03841 | 920 | 19.16 | Mlig455_018790, Mlig455_048140 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.474 Region-enriched R2: 5.915/0.00081 |
NKX2-1, NKX2-4 | 2.524 | - | - | - | 0.798 | 0.966 | 0.760 | Mlig455_018790 {REF} {Length: 2203} {Pfam: Homeodomain [PF00046.31, score=72.7]} {Human: ENSG00000136352, NKX2-1, NK2 homeobox 1, [RH, Score=145, Expect=2e-39]; ENSG00000125816, NKX2-4, NK2 homeobox 4, [RH, Score=145, Expect=2e-39]} {Mouse: ENSMUSG00000001496, Nkx2-1, NK2 homeobox 1, [RH, Score=145, Expect=2e-39]} {Dmel: FBgn0028993, scro, scarecrow, [RH, Score=166, Expect=8e-47]} {Celegans: WBGene00000447, ceh-24, Homeobox protein ceh-24, [RH, Score=134, Expect=2e-36]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [RH, Score=191, Expect=1e-57]} {RNA1509_12761} {RNA1310_13401} {RNA815_21584} Mlig455_048140 {REF} {Length: 2218} {Pfam: Homeodomain [PF00046.31, score=72.5]} {Human: ENSG00000125816, NKX2-4, NK2 homeobox 4, [RH, Score=145, Expect=3e-39]; ENSG00000136352, NKX2-1, NK2 homeobox 1, [RH, Score=145, Expect=7e-39]} {Mouse: ENSMUSG00000001496, Nkx2-1, NK2 homeobox 1, [RH, Score=144, Expect=6e-39]} {Dmel: FBgn0028993, scro, scarecrow, [RH, Score=166, Expect=2e-46]} {Celegans: WBGene00000447, ceh-24, Homeobox protein ceh-24, [RH, Score=136, Expect=1e-36]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [RH, Score=193, Expect=1e-57]} {RNA1509_12761} {RNA1310_13401, RNA1509_12761} {RNA1509_12761, RNA815_21584} |
19. | MligTC455_39467 | 6156 | 128.24 | Mlig455_066728, Mlig455_066742 | Neo: - Age: logFC(26M/2M)=-0.137 Region-specific R2: 2.002 Region-enriched R2: 1.402/0.00004 |
PC | 2.521 | - | - | - | 0.777 | 0.965 | 0.779 | Mlig455_066728 {REF} {Length: 4310} {TRANSSPLICED} {Pfam: Carbamoyl-phosphate synthase L chain, ATP binding domain [PF02786.19, score=220.4]; Conserved carboxylase domain [PF02436.20, score=216.0]; Biotin carboxylase, N-terminal domain [PF00289.24, score=144.7]; Biotin carboxylase C-terminal domain [PF02785.21, score=102.8]; HMGL-like [PF00682.21, score=93.0]; Biotin-requiring enzyme [PF00364.24, score=57.9]; Biotin-lipoyl like [PF13533.8, score=28.3]; D-ala D-ala ligase C-terminus [PF07478.15, score=25.5]; ATP-grasp domain [PF02222.24, score=24.6]} {Human: ENSG00000173599, PC, pyruvate carboxylase, [Score=1375, Expect=0.0]} {Mouse: ENSMUSG00000024892, Pcx, pyruvate carboxylase, [Score=1365, Expect=0.0]} {Dmel: FBgn0027580, PCB, Pyruvate carboxylase, [Score=1419, Expect=0.0]} {Celegans: WBGene00004258, pyc-1, Pyruvate carboxylase 1, [Score=1371, Expect=0.0]} {Smed: dd_Smed_v6_2393_0_1, dd_Smed_v6_2393_0_1, [Score=1440, Expect=0.0]} {RNA1509_292} {RNA1310_1178} {RNA815_516.1} Mlig455_066742 {REF} {Length: 4334} {TRANSSPLICED} {Pfam: Carbamoyl-phosphate synthase L chain, ATP binding domain [PF02786.19, score=265.4]; Biotin carboxylase, N-terminal domain [PF00289.24, score=117.2]; Biotin carboxylase C-terminal domain [PF02785.21, score=104.0]; ATP-grasp domain [PF02222.24, score=37.0]; D-ala D-ala ligase C-terminus [PF07478.15, score=34.3]; ATP-grasp domain [PF02655.16, score=18.8]; HMGL-like [PF00682.21, score=18.3]} {Human: ENSG00000173599, PC, pyruvate carboxylase, [Score=837, Expect=0.0]} {Mouse: ENSMUSG00000024892, Pcx, pyruvate carboxylase, [Score=826, Expect=0.0]} {Dmel: FBgn0027580, PCB, Pyruvate carboxylase, [Score=839, Expect=0.0]} {Celegans: WBGene00004258, pyc-1, Pyruvate carboxylase 1, [Score=808, Expect=0.0]} {Smed: dd_Smed_v6_2393_0_1, dd_Smed_v6_2393_0_1, [Score=851, Expect=0.0]} {RNA1509_10828, RNA1509_18927, RNA1509_292, RNA1509_34195, RNA1509_44579} {RNA1310_1642, RNA1509_10828, RNA1509_18927, RNA1509_292, RNA1509_34195, RNA1509_44579} {RNA1509_10828, RNA1509_18927, RNA1509_292, RNA1509_34195, RNA1509_44579, RNA815_516.1} |
20. | MligTC455_22994 | 337 | 7.02 | Mlig455_008846 | Neo: - Age: Down-Up-Up |
2.495 | - | - | - | 0.743 | 0.954 | 0.798 | Mlig455_008846 {REF} {Length: 1548} {Pfam: SPATIAL [PF15256.8, score=72.1]} {Mouse: ENSMUSG00000020096, Tbata, thymus, brain and testes associated, [Score=48.5, Expect=9e-06]} {Smed: dd_Smed_v6_4229_0_1, dd_Smed_v6_4229_0_1, [RH, Score=62.0, Expect=2e-10]} {RNA1509_46671} {RNA1310_22194.1, RNA1509_46671} {RNA1509_46671, RNA815_29404} | |
21. | MligTC455_50567 | 146 | 3.04 | Mlig455_012858 | Neo: - Age: - Region-specific R2: 6.162 Region-enriched R2: 5.988/0.01054 |
2.492 | - | - | - | 0.791 | 0.961 | 0.740 | Mlig455_012858 {REF} {Length: 1282} {Pfam: F5/8 type C domain [PF00754.27, score=27.5]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [RH, Score=64.3, Expect=4e-12]} {RNA1310_34633} {RNA815_12537} | |
22. | MligTC455_18787 | 963 | 20.06 | Mlig455_014022 | Neo: - Age: - Region-enriched R2: 1.334/0.03482 |
STRC | 2.489 | 0.724 | - | - | 0.815 | 0.950 | - | Mlig455_014022 {REF} {Length: 5754} {Human: ENSG00000242866, STRC, stereocilin, [RH, Score=76.3, Expect=4e-13]} {Mouse: ENSMUSG00000033498, Strc, stereocilin, [RH, Score=80.9, Expect=1e-14]} {RNA1509_4378} {RNA1310_1493.1, RNA1509_4378} {RNA1509_4378, RNA815_804} |
23. | MligTC455_47806 | 2724 | 56.76 | Mlig455_033677 | Neo: - Age: - Region-specific R2: 3.773 Region-enriched R2: 2.504/0.00005 |
2.488 | - | - | - | 0.724 | 0.963 | 0.801 | Mlig455_033677 {REF} {Length: 1836} {RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504} {RNA1310_30659.1, RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504} {RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504, RNA815_13807} | |
24. | MligTC455_18564 | 196 | 4.08 | Mlig455_063527 | Neo: - Age: - Region-enriched R2: 2.416/0.01839 |
PRKG2 | 2.483 | - | - | - | 0.764 | 0.988 | 0.731 | Mlig455_063527 {REF} {Length: 2971} {Pfam: Protein kinase domain [PF00069.27, score=212.4]; Cyclic nucleotide-binding domain [PF00027.31, score=135.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=103.7]; Kinase-like [PF14531.8, score=24.8]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=653, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=651, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=662, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=655, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=645, Expect=0.0]} {RNA1509_38353} {RNA1310_8466, RNA1509_38353} {RNA1509_38353, RNA815_6313} |
25. | MligTC455_47807 | 2664 | 55.5 | Mlig455_050143 | Neo: - Age: - Region-specific R2: 3.807 Region-enriched R2: 2.561/0.00001 |
2.476 | - | - | - | 0.714 | 0.963 | 0.799 | Mlig455_050143 {REF} {Length: 1560} {RNA1509_1605, RNA1509_28756} {RNA1310_30659.1, RNA1509_28756} {RNA1509_28756, RNA815_13807} | |
26. | MligTC455_27025 | 706 | 14.7 | Mlig455_054786, Mlig455_054878 | Neo: - Age: - Region-enriched R2: 3.519/0.00005 |
CD82 | 2.416 | - | - | - | 0.718 | 0.962 | 0.736 | Mlig455_054786 {REF} {Length: 2796} {Pfam: Tetraspanin family [PF00335.22, score=142.8]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=86.3, Expect=4e-19]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=94.0, Expect=3e-22]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=98.6, Expect=6e-24]} {Celegans: WBGene00006632, tsp-6, Tetraspanin, [Score=74.7, Expect=1e-15]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1310_8032.1, RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1509_20389, RNA1509_43644, RNA1509_56428, RNA815_3380.1} Mlig455_054878 {REF} {Length: 4398} {Pfam: Tetraspanin family [PF00335.22, score=143.7]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=84.7, Expect=2e-18]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=92.4, Expect=2e-21]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=99.8, Expect=4e-24]} {Celegans: WBGene00006643, tsp-17, TetraSPanin family, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_56428} {RNA1310_8032.2} {RNA815_3380.1} |
27. | MligTC455_28457 | 1836 | 38.25 | Mlig455_047188, Mlig455_048490 | Neo: - Age: logFC(26M/2M)=-0.228 |
RSPH10B2 | 1.898 | - | - | - | 0.956 | 0.942 | - | Mlig455_047188 {REF} {Length: 3292} {TRANSSPLICED} {Pfam: MORN repeat [PF02493.22, score=169.8]} {Human: ENSG00000169402, RSPH10B2, radial spoke head 10 homolog B2, [RH, Score=435, Expect=9e-137]; ENSG00000155026, RSPH10B, radial spoke head 10 homolog B, [RH, Score=431, Expect=3e-135]} {Mouse: ENSMUSG00000075569, Rsph10b, radial spoke head 10 homolog B (Chlamydomonas), [RH, Score=435, Expect=5e-137]} {Dmel: FBgn0050429, CG30429, [Score=88.2, Expect=1e-18]} {Celegans: WBGene00002179, jph-1, JunctoPHilin, [Score=77.0, Expect=4e-14]} {Smed: dd_Smed_v6_12762_0_1, dd_Smed_v6_12762_0_1, [RH, Score=524, Expect=5e-171]} {RNA1509_2912} {RNA1310_4817} {RNA815_4683.1} Mlig455_048490 {REF} {Length: 3647} {TRANSSPLICED} {Pfam: MORN repeat [PF02493.22, score=169.8]} {Human: ENSG00000169402, RSPH10B2, radial spoke head 10 homolog B2, [RH, Score=434, Expect=2e-136]; ENSG00000155026, RSPH10B, radial spoke head 10 homolog B, [RH, Score=429, Expect=1e-134]} {Mouse: ENSMUSG00000075569, Rsph10b, radial spoke head 10 homolog B (Chlamydomonas), [RH, Score=434, Expect=2e-136]} {Dmel: FBgn0050429, CG30429, [Score=88.2, Expect=1e-18]} {Celegans: WBGene00002179, jph-1, JunctoPHilin, [Score=77.0, Expect=4e-14]} {Smed: dd_Smed_v6_12762_0_1, dd_Smed_v6_12762_0_1, [RH, Score=525, Expect=1e-171]} {RNA1509_2912} {RNA1310_4817, RNA1509_2912} {RNA1509_2912, RNA815_4683.1} |
28. | MligTC455_34483 | 299 | 6.22 | Mlig455_026230, Mlig455_026246, Mlig455_052726 | Neo: - Age: - Region-enriched R4: 4.361/0.00055 |
GLRA2, GLRA3 | 1.856 | - | - | - | 0.889 | 0.967 | - | Mlig455_026230 {REF} {Length: 1814} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=127.9]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=344, Expect=2e-113]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=341, Expect=3e-112]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=339, Expect=1e-111]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=341, Expect=3e-112]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=339, Expect=7e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=337, Expect=5e-111]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=334, Expect=1e-109]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=301, Expect=6e-97]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=282, Expect=1e-88]} {Smed: dd_Smed_v6_14666_0_1, dd_Smed_v6_14666_0_1, [Score=256, Expect=4e-80]} {RNA1509_44790} {RNA1310_18963, RNA1509_44790} {RNA1509_44790, RNA815_26083} Mlig455_026246 {REF} {Length: 1934} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=76.3]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=46.8]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=176, Expect=2e-52]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=175, Expect=5e-51]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=175, Expect=7e-51]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=174, Expect=7e-51]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=176, Expect=1e-51]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=175, Expect=5e-52]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=175, Expect=4e-51]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=169, Expect=9e-49]} {Dmel: FBgn0024963, GluClalpha, [Score=151, Expect=2e-42]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=149, Expect=6e-41]} {Smed: dd_Smed_v6_25116_0_1, dd_Smed_v6_25116_0_1, [Score=135, Expect=3e-36]} {RNA1509_44790} {RNA1310_18963} {RNA815_12996} Mlig455_052726 {REF} {Length: 2299} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=128.3]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=342, Expect=1e-113]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=340, Expect=8e-113]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=337, Expect=1e-111]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=341, Expect=4e-113]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=338, Expect=3e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=335, Expect=2e-111]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=331, Expect=1e-109]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=296, Expect=6e-96]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=281, Expect=2e-89]} {Smed: dd_Smed_v6_14666_0_1, dd_Smed_v6_14666_0_1, [Score=251, Expect=5e-79]} {RNA1509_44790} {RNA1310_18963} {RNA815_26083} |
29. | MligTC455_44449 | 1235 | 25.73 | Mlig455_046782, Mlig455_046804, Mlig455_069958 | Neo: - Age: - |
1.848 | - | - | 0.968 | 0.880 | - | - | Mlig455_046782 {REF} {Length: 3844} {TRANSSPLICED} {Pfam: Coiled-coil protein 142 [PF14923.8, score=60.9]} {Smed: dd_Smed_v6_17993_0_1, dd_Smed_v6_17993_0_1, [RH, Score=174, Expect=2e-44]} {RNA1509_21784} {RNA1310_7746} {RNA815_16917.1} Mlig455_046804 {REF} {Length: 3964} {TRANSSPLICED} {Pfam: Coiled-coil protein 142 [PF14923.8, score=60.0]} {Smed: dd_Smed_v6_17993_0_1, dd_Smed_v6_17993_0_1, [Score=99.8, Expect=5e-21]} {RNA1509_21784} {RNA1310_7746, RNA1509_21784} {RNA1509_21784, RNA815_16917.1} Mlig455_069958 {REF} {Length: 3952} {TRANSSPLICED} {Pfam: Coiled-coil protein 142 [PF14923.8, score=60.7]} {Smed: dd_Smed_v6_17993_0_1, dd_Smed_v6_17993_0_1, [Score=97.1, Expect=3e-20]} {RNA1509_21784} {RNA1310_7746} {RNA815_16917.1} |
|
30. | MligTC455_52763 | 595 | 12.4 | Mlig455_020629, Mlig455_048817 | Neo: Irradiation Age: Up-Down-Up |
DLC1 | 1.839 | - | - | - | 0.970 | 0.869 | - | Mlig455_020629 {REF} {Length: 4722} {Pfam: RhoGAP domain [PF00620.29, score=111.4]; START domain [PF01852.21, score=54.0]} {Human: ENSG00000164741, DLC1, DLC1 Rho GTPase activating protein, [RH, Score=375, Expect=1e-112]; ENSG00000285265, DLC1, DLC1 Rho GTPase activating protein, [RH, Score=375, Expect=1e-112]} {Mouse: ENSMUSG00000031523, Dlc1, deleted in liver cancer 1, [RH, Score=371, Expect=3e-108]} {Dmel: FBgn0285955, cv-c, crossveinless c, [RH, Score=341, Expect=1e-97]} {Celegans: WBGene00001559, gei-1, GEX Interacting protein, [RH, Score=228, Expect=9e-61]} {Smed: dd_Smed_v6_9530_0_1, dd_Smed_v6_9530_0_1, [RH, Score=344, Expect=1e-102]} {RNA1509_29640} {RNA1310_9000} {RNA815_6507} Mlig455_048817 {REF} {Length: 3722} {Pfam: RhoGAP domain [PF00620.29, score=111.4]; START domain [PF01852.21, score=52.4]} {Human: ENSG00000285265, DLC1, DLC1 Rho GTPase activating protein, [RH, Score=380, Expect=3e-111]; ENSG00000164741, DLC1, DLC1 Rho GTPase activating protein, [RH, Score=380, Expect=3e-111]} {Mouse: ENSMUSG00000031523, Dlc1, deleted in liver cancer 1, [RH, Score=375, Expect=1e-109]} {Dmel: FBgn0285955, cv-c, crossveinless c, [RH, Score=344, Expect=1e-98]} {Celegans: WBGene00001559, gei-1, GEX Interacting protein, [RH, Score=231, Expect=7e-62]} {Smed: dd_Smed_v6_9530_0_1, dd_Smed_v6_9530_0_1, [RH, Score=343, Expect=2e-102]} {RNA1509_29640} {RNA1310_9000} {RNA815_6507} |
31. | MligTC455_40657 | 90 | 1.87 | Mlig455_040779 | Neo: - Age: - |
CLIP2 | 1.834 | - | - | - | 0.874 | 0.960 | - | Mlig455_040779 {REF} {Length: 2164} {Pfam: CAP-Gly domain [PF01302.27, score=60.7]} {Human: ENSG00000106665, CLIP2, CAP-Gly domain containing linker protein 2, [Score=61.6, Expect=2e-09]} {Mouse: ENSMUSG00000063146, Clip2, CAP-GLY domain containing linker protein 2, [Score=62.0, Expect=1e-09]} {Dmel: FBgn0036882, CG9279, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12985_0_1, dd_Smed_v6_12985_0_1, [Score=56.2, Expect=2e-08]} {RNA1310_20676} {RNA815_40746} |
32. | MligTC455_31164 | 572 | 11.91 | Mlig455_029609, Mlig455_045673 | Neo: - Age: - |
1.831 | - | - | - | 0.849 | 0.982 | - | Mlig455_029609 {REF} {Length: 746} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=39.4]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=48.5, Expect=1e-06]} {RNA1310_96354} {RNA815_44390} Mlig455_045673 {REF} {Length: 2025} {RNA1509_21720} {RNA1310_14760} {RNA815_24583} |
|
33. | MligTC455_48651 | 1312 | 27.33 | Mlig455_038678 | Neo: - Age: - Region-specific R2: 3.201 Region-enriched R2: 2.599/0.00005 |
PTPRN | 1.823 | - | - | 0.850 | - | 0.973 | - | Mlig455_038678 {REF} {Length: 3539} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=232.2]} {Human: ENSG00000054356, PTPRN, protein tyrosine phosphatase, receptor type N, [RH, Score=424, Expect=2e-134]; ENSG00000155093, PTPRN2, protein tyrosine phosphatase, receptor type N2, [RH, Score=417, Expect=1e-130]} {Mouse: ENSMUSG00000026204, Ptprn, protein tyrosine phosphatase, receptor type, N, [RH, Score=428, Expect=3e-135]; ENSMUSG00000056553, Ptprn2, protein tyrosine phosphatase, receptor type, N polypeptide 2, [RH, Score=413, Expect=3e-129]} {Dmel: FBgn0031294, IA-2, IA-2 protein tyrosine phosphatase, [RH, Score=390, Expect=2e-118]} {Celegans: WBGene00002048, ida-1, IA2; IDA-1 protein; Related to Islet cell Diabetes Autoantigen, [Score=287, Expect=8e-85]} {Smed: dd_Smed_v6_6990_0_1, dd_Smed_v6_6990_0_1, [RH, Score=397, Expect=2e-126]} {RNA1509_1051, RNA1509_26823, RNA1509_32982, RNA1509_35716} {RNA1310_3791, RNA1509_1051, RNA1509_26823, RNA1509_32982, RNA1509_35716} {RNA1509_1051, RNA1509_26823, RNA1509_32982, RNA1509_35716, RNA815_1009} |
34. | MligTC455_05175 | 15 | 0.31 | Mlig455_040087 | Neo: - Age: - |
FCN2 | 1.82 | - | - | - | 0.861 | 0.959 | - | Mlig455_040087 {REF} {Length: 1203} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=103.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=94.7, Expect=2e-22]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=94.7, Expect=2e-21]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=94.0, Expect=2e-21]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=92.4, Expect=3e-21]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=92.4, Expect=8e-21]} {Dmel: FBgn0050280, CG30280, [Score=90.1, Expect=6e-21]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=99.8, Expect=2e-23]} {RNA1509_54507} {RNA1310_27399} {RNA815_12335} |
35. | MligTC455_05174 | 15 | 0.3 | Mlig455_040060 | Neo: - Age: - |
ANGPTL6 | 1.819 | - | - | - | 0.861 | 0.958 | - | Mlig455_040060 {REF} {Length: 1046} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=103.3]} {Human: ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=96.7, Expect=7e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=95.9, Expect=2e-22]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=93.6, Expect=3e-21]} {Mouse: ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=94.0, Expect=4e-21]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.0, Expect=1e-21]} {Dmel: FBgn0050280, CG30280, [Score=91.7, Expect=2e-21]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=99.4, Expect=3e-23]} {RNA1509_54507} {RNA1310_27399} {RNA815_12335} |
36. | MligTC455_39736 | 474 | 9.86 | Mlig455_014716 | Neo: - Age: Up-Down-Up |
1.819 | - | - | - | - | 0.856 | 0.963 | Mlig455_014716 {REF} {Length: 3097} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4537) [PF15057.8, score=61.8]; von Willebrand factor type A domain [PF13768.8, score=19.6]} {Smed: dd_Smed_v6_10837_0_1, dd_Smed_v6_10837_0_1, [RH, Score=97.4, Expect=1e-20]} {RNA1509_28750} {RNA1310_4730} {RNA815_8808} | |
37. | MligTC455_46394 | 8810 | 183.54 | Mlig455_054818, Mlig455_054826 | Neo: - Age: - Region-specific R2: 1.771 Region-enriched R2: 1.255/0.00038 |
PKD2 | 1.818 | - | - | - | 0.840 | 0.978 | - | Mlig455_054818 {REF} {Length: 2992} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=750, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=747, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=380, Expect=6e-120]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=733, Expect=0.0]} {RNA1509_1615} {RNA1310_21296.2, RNA1509_1615} {RNA1509_1615, RNA815_3158.1} Mlig455_054826 {REF} {Length: 3118} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.4]; EF hand [PF00036.34, score=32.6]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=754, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=751, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=2e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
38. | MligTC455_42996 | 1278 | 26.63 | Mlig455_063418, Mlig455_066633 | Neo: - Age: logFC(26M/2M)=-0.327 Region-enriched R2: 1.738/0.03767 |
DYRK2 | 1.817 | - | - | - | 0.864 | 0.953 | - | Mlig455_063418 {REF} {Length: 2420} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=193.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=85.6]; ABC1 atypical kinase-like domain [PF03109.18, score=24.3]; Phosphotransferase enzyme family [PF01636.25, score=22.4]; RIO1 family [PF01163.24, score=18.5]} {Human: ENSG00000127334, DYRK2, dual specificity tyrosine phosphorylation regulated kinase 2, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000028630, Dyrk2, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2, [RH, Score=633, Expect=0.0]} {Dmel: FBgn0027101, Dyrk3, Dual-specificity tyrosine phosphorylation-regulated kinase 3, [RH, Score=542, Expect=0.0]} {Celegans: WBGene00003150, mbk-2, Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2, [RH, Score=577, Expect=0.0]} {Smed: dd_Smed_v6_10966_0_1, dd_Smed_v6_10966_0_1, [RH, Score=612, Expect=0.0]} {RNA1509_27355, RNA1509_7341} {RNA1310_9403, RNA1509_7341} {RNA1509_7341, RNA815_3107} Mlig455_066633 {REF} {Length: 2424} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=193.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=85.6]; ABC1 atypical kinase-like domain [PF03109.18, score=24.3]; Phosphotransferase enzyme family [PF01636.25, score=22.4]; RIO1 family [PF01163.24, score=18.5]} {Human: ENSG00000127334, DYRK2, dual specificity tyrosine phosphorylation regulated kinase 2, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000028630, Dyrk2, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2, [RH, Score=633, Expect=0.0]} {Dmel: FBgn0027101, Dyrk3, Dual-specificity tyrosine phosphorylation-regulated kinase 3, [RH, Score=542, Expect=0.0]} {Celegans: WBGene00003150, mbk-2, Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2, [RH, Score=577, Expect=0.0]} {Smed: dd_Smed_v6_10966_0_1, dd_Smed_v6_10966_0_1, [RH, Score=612, Expect=0.0]} {RNA1509_18793, RNA1509_27355} {RNA1310_9403, RNA1509_18793, RNA1509_27355} {RNA1509_18793, RNA1509_27355, RNA815_3107} |
39. | MligTC455_49623 | 1254 | 26.13 | Mlig455_005003, Mlig455_005044, Mlig455_005273 | Neo: - Age: Down-Up-Up Region-enriched R4: 1.089/0.03938 |
MAPRE1 | 1.807 | - | - | 0.956 | - | - | 0.851 | Mlig455_005003 {REF} {Length: 1466} {TRANSSPLICED} {Pfam: EB1-like C-terminal motif [PF03271.19, score=48.5]; Calponin homology (CH) domain [PF00307.33, score=45.4]} {Human: ENSG00000101367, MAPRE1, microtubule associated protein RP/EB family member 1, [RH, Score=256, Expect=1e-84]; ENSG00000084764, MAPRE3, microtubule associated protein RP/EB family member 3, [RH, Score=247, Expect=5e-81]} {Mouse: ENSMUSG00000027479, Mapre1, microtubule-associated protein, RP/EB family, member 1, [RH, Score=255, Expect=2e-84]; ENSMUSG00000029166, Mapre3, microtubule-associated protein, RP/EB family, member 3, [RH, Score=244, Expect=5e-80]} {Dmel: FBgn0027066, Eb1, [RH, Score=258, Expect=1e-85]} {Celegans: WBGene00013344, ebp-1, Microtubule End Binding Protein, [RH, Score=218, Expect=2e-69]} {Smed: dd_Smed_v6_1322_0_2, dd_Smed_v6_1322_0_2, [RH, Score=309, Expect=3e-105]} {RNA1509_15908} {RNA1310_22066} {RNA815_24384} Mlig455_005044 {REF} {Length: 1464} {TRANSSPLICED} {Pfam: EB1-like C-terminal motif [PF03271.19, score=48.5]; Calponin homology (CH) domain [PF00307.33, score=45.4]} {Human: ENSG00000101367, MAPRE1, microtubule associated protein RP/EB family member 1, [RH, Score=256, Expect=1e-84]; ENSG00000084764, MAPRE3, microtubule associated protein RP/EB family member 3, [RH, Score=247, Expect=5e-81]} {Mouse: ENSMUSG00000027479, Mapre1, microtubule-associated protein, RP/EB family, member 1, [RH, Score=255, Expect=2e-84]; ENSMUSG00000029166, Mapre3, microtubule-associated protein, RP/EB family, member 3, [RH, Score=244, Expect=5e-80]} {Dmel: FBgn0027066, Eb1, [RH, Score=258, Expect=1e-85]} {Celegans: WBGene00013344, ebp-1, Microtubule End Binding Protein, [RH, Score=218, Expect=2e-69]} {Smed: dd_Smed_v6_1322_0_2, dd_Smed_v6_1322_0_2, [RH, Score=309, Expect=3e-105]} {RNA1509_15908} {RNA1310_22066} {RNA815_24384} Mlig455_005273 {REF} {Length: 1471} {TRANSSPLICED} {Pfam: EB1-like C-terminal motif [PF03271.19, score=48.5]; Calponin homology (CH) domain [PF00307.33, score=45.4]} {Human: ENSG00000101367, MAPRE1, microtubule associated protein RP/EB family member 1, [RH, Score=256, Expect=1e-84]; ENSG00000084764, MAPRE3, microtubule associated protein RP/EB family member 3, [RH, Score=247, Expect=5e-81]} {Mouse: ENSMUSG00000027479, Mapre1, microtubule-associated protein, RP/EB family, member 1, [RH, Score=255, Expect=2e-84]; ENSMUSG00000029166, Mapre3, microtubule-associated protein, RP/EB family, member 3, [RH, Score=244, Expect=5e-80]} {Dmel: FBgn0027066, Eb1, [RH, Score=258, Expect=1e-85]} {Celegans: WBGene00013344, ebp-1, Microtubule End Binding Protein, [RH, Score=218, Expect=2e-69]} {Smed: dd_Smed_v6_1322_0_2, dd_Smed_v6_1322_0_2, [RH, Score=309, Expect=3e-105]} {RNA1509_15908} {RNA1310_22066} {RNA815_24384} |
40. | MligTC455_22979 | 1736 | 36.17 | Mlig455_061961 | Neo: - Age: logFC(26M/2M)=-0.302 |
CFAP43 | 1.805 | - | - | - | 0.952 | 0.853 | - | Mlig455_061961 {REF} {Length: 5985} {Human: ENSG00000197748, CFAP43, cilia and flagella associated protein 43, [RH, Score=528, Expect=5e-164]} {Mouse: ENSMUSG00000044948, Cfap43, cilia and flagella associated protein 43, [Score=554, Expect=2e-167]} {Dmel: FBgn0036348, CG17687, [RH, Score=118, Expect=3e-26]} {Smed: dd_Smed_v6_10271_0_1, dd_Smed_v6_10271_0_1, [Score=724, Expect=0.0]} {RNA1509_53795} {RNA1310_1696} {RNA815_196.1} |
41. | MligTC455_22978 | 1713 | 35.69 | Mlig455_009568 | Neo: - Age: - |
CFAP43 | 1.8 | - | - | - | 0.953 | 0.847 | - | Mlig455_009568 {REF} {Length: 1031} {Human: ENSG00000197748, CFAP43, cilia and flagella associated protein 43, [Score=60.5, Expect=8e-12]} {Mouse: ENSMUSG00000044948, Cfap43, cilia and flagella associated protein 43, [Score=56.6, Expect=1e-10]} {Smed: dd_Smed_v6_10271_0_3, dd_Smed_v6_10271_0_3, [Score=71.2, Expect=3e-16]} {RNA1509_53795} {RNA1310_29288} {RNA815_196.1} |
42. | MligTC455_17561 | 189 | 3.94 | Mlig455_020268 | Neo: - Age: - Region-enriched R2: 4.198/0.00004 |
NECAB3 | 1.795 | - | - | - | - | 0.961 | 0.834 | Mlig455_020268 {REF} {Length: 1518} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=192, Expect=6e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461, RNA1509_46831} {RNA1509_46831, RNA815_25216} |
43. | MligTC455_03696 | 75 | 1.57 | Mlig455_007008 | Neo: - Age: - |
CACNA1H | 1.791 | - | - | - | 0.839 | 0.952 | - | Mlig455_007008 {REF} {Length: 6530} {Pfam: Ion transport protein [PF00520.33, score=430.6]; Polycystin cation channel [PF08016.14, score=56.2]} {Human: ENSG00000196557, CACNA1H, calcium voltage-gated channel subunit alpha1 H, [Score=836, Expect=0.0]} {Mouse: ENSMUSG00000024112, Cacna1h, calcium channel, voltage-dependent, T type, alpha 1H subunit, [Score=838, Expect=0.0]} {Dmel: FBgn0264386, Ca-alpha1T, Ca[2+]-channel protein alpha[[1]] subunit T, [RH, Score=857, Expect=0.0]} {Celegans: WBGene00000367, cca-1, Voltage-dependent T-type calcium channel subunit alpha, [RH, Score=761, Expect=0.0]} {Smed: dd_Smed_v6_16822_0_1, dd_Smed_v6_16822_0_1, [RH, Score=916, Expect=0.0]} {RNA1509_28376} {RNA1310_9083} {RNA815_21869} |
44. | MligTC455_49307 | 122 | 2.55 | Mlig455_055230 | Neo: - Age: - Region-enriched R2: 4.447/0.04819 |
ZAN | 1.791 | - | - | - | 0.822 | 0.969 | - | Mlig455_055230 {REF} {Length: 2947} {Pfam: Glycine rich protein [PF12810.9, score=28.6]} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=79.7, Expect=1e-14]} {Mouse: ENSMUSG00000079173, Zan, zonadhesin, [Score=80.1, Expect=7e-15]} {RNA1310_18897} {RNA815_40026} |
45. | MligTC455_46305 | 450 | 9.39 | Mlig455_047530 | Neo: - Age: Down-Up-Down |
PTBP3 | 1.786 | - | - | - | 0.969 | 0.817 | - | Mlig455_047530 {REF} {Length: 3409} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=152.2]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=112.0]; RRM-like domain [PF11835.10, score=52.5]; Occluded RNA-recognition motif [PF16842.7, score=43.9]; RNA binding motif [PF08777.13, score=18.6]} {Human: ENSG00000119314, PTBP3, polypyrimidine tract binding protein 3, [RH, Score=466, Expect=9e-157]; ENSG00000117569, PTBP2, polypyrimidine tract binding protein 2, [RH, Score=465, Expect=1e-156]; ENSG00000011304, PTBP1, polypyrimidine tract binding protein 1, [RH, Score=464, Expect=7e-156]} {Mouse: ENSMUSG00000028382, Ptbp3, polypyrimidine tract binding protein 3, [RH, Score=468, Expect=7e-158]; ENSMUSG00000006498, Ptbp1, polypyrimidine tract binding protein 1, [RH, Score=468, Expect=8e-158]; ENSMUSG00000028134, Ptbp2, polypyrimidine tract binding protein 2, [RH, Score=467, Expect=9e-158]} {Dmel: FBgn0011224, heph, hephaestus, [RH, Score=442, Expect=1e-144]} {Celegans: WBGene00004207, ptb-1, PTB (HnRNP) homolog; Putative RNA-binding protein PTB-1b, [RH, Score=422, Expect=2e-139]} {Smed: dd_Smed_v6_14748_0_1, dd_Smed_v6_14748_0_1, [RH, Score=338, Expect=7e-107]} {RNA1509_47625, RNA1509_7362} {RNA1310_5320, RNA1509_47625} {RNA1509_47625, RNA815_1604} |
46. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
1.77 | - | - | - | 0.814 | 0.956 | - | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
47. | MligTC455_14715 | 31 | 0.65 | Mlig455_043609 | Neo: - Age: - |
ANGPTL1 | 1.76 | - | - | - | 0.799 | 0.961 | - | Mlig455_043609 {REF} {Length: 1252} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=154.2]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=131, Expect=2e-34]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=128, Expect=2e-33]; ENSG00000085265, FCN1, ficolin 1, [Score=128, Expect=2e-34]; ENSG00000160339, FCN2, ficolin 2, [Score=125, Expect=5e-34]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=134, Expect=1e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=129, Expect=7e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=128, Expect=2e-33]} {Dmel: FBgn0033312, CG8642, [RH, Score=122, Expect=1e-31]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=112, Expect=7e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
48. | MligTC455_16415 | 197 | 4.1 | Mlig455_000401 | Neo: - Age: - Region-enriched R2: 4.276/0.00982 |
ROR1 | 1.753 | - | - | - | 0.800 | 0.953 | - | Mlig455_000401 {REF} {Length: 3780} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=233.3]; Protein kinase domain [PF00069.27, score=85.9]; Immunoglobulin I-set domain [PF07679.18, score=49.4]; Immunoglobulin domain [PF13927.8, score=46.6]; Immunoglobulin domain [PF00047.27, score=31.9]; Immunoglobulin domain [PF13895.8, score=30.0]; Fz domain [PF01392.24, score=27.6]; Kringle domain [PF00051.20, score=22.3]; Immunoglobulin V-set domain [PF07686.19, score=19.5]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [RH, Score=390, Expect=1e-119]; ENSG00000169071, ROR2, receptor tyrosine kinase like orphan receptor 2, [RH, Score=379, Expect=1e-115]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [RH, Score=386, Expect=1e-118]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [RH, Score=377, Expect=4e-115]} {Dmel: FBgn0010407, Ror, [Score=286, Expect=3e-84]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=285, Expect=4e-82]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [RH, Score=439, Expect=2e-139]} {RNA1509_35395} {RNA1310_13558, RNA1509_35395} {RNA1509_35395, RNA815_27446} |
49. | MligTC455_23582 | 290 | 6.04 | Mlig455_043258 | Neo: - Age: logFC(26M/2M)=-1.253 |
CCDC33 | 1.744 | - | - | - | 0.957 | - | 0.787 | Mlig455_043258 {REF} {Length: 3463} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=24.6]; C-terminal membrane-localisation domain of ion-channel, VCN1 [PF16799.7, score=19.4]} {Human: ENSG00000140481, CCDC33, coiled-coil domain containing 33, [RH, Score=94.7, Expect=4e-19]} {Mouse: ENSMUSG00000037716, Ccdc33, coiled-coil domain containing 33, [RH, Score=165, Expect=3e-41]} {Smed: dd_Smed_v6_15844_0_1, dd_Smed_v6_15844_0_1, [RH, Score=195, Expect=4e-51]} {RNA1509_7141} {RNA1310_3740, RNA1509_7141} {RNA1509_7141, RNA815_780.1} |
50. | MligTC455_25588 | 1046 | 21.8 | Mlig455_029794 | Neo: - Age: - Region-enriched R2: 2.896/0.00002 |
1.741 | - | - | - | - | 0.967 | 0.774 | Mlig455_029794 {REF} {Length: 1354} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=40.1]; Domain of unknown function (DUF1848) [PF08902.13, score=20.8]} {RNA1509_17753} {RNA1310_70608} {RNA815_1498.1} | |
51. | MligTC455_42088 | 72 | 1.5 | Mlig455_028244 | Neo: - Age: - |
1.737 | - | - | - | 0.787 | 0.950 | - | Mlig455_028244 {REF} {Length: 2632} {RNA1509_40406} {RNA1310_12938} {RNA815_16887} | |
52. | MligTC455_36667 | 84 | 1.75 | Mlig455_016177 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.440 Region-enriched R2: 4.490/0.00556 |
1.735 | - | - | - | 0.778 | 0.957 | - | Mlig455_016177 {REF} {Length: 3035} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=47.6]; Immunoglobulin domain [PF13927.8, score=47.0]; Immunoglobulin domain [PF00047.27, score=32.1]; Immunoglobulin domain [PF13895.8, score=27.4]; Natural killer cell receptor 2B4 [PF11465.10, score=26.4]; Immunoglobulin V-set domain [PF07686.19, score=23.5]} {Dmel: FBgn0259245, DIP-beta, Dpr-interacting protein beta, [Score=58.9, Expect=3e-09]} {Celegans: WBGene00006985, zig-8, Zwei Ig domain protein zig-8, [RH, Score=57.0, Expect=4e-09]} {Smed: dd_Smed_v6_21969_0_1, dd_Smed_v6_21969_0_1, [Score=72.0, Expect=6e-14]} {RNA1509_49618} {RNA1310_15195} {RNA815_58259} | |
53. | MligTC455_13682 | 42 | 0.87 | Mlig455_030673 | Neo: - Age: - |
1.733 | - | - | - | 0.770 | 0.963 | - | Mlig455_030673 {REF} {Length: 2472} {Pfam: gag-polyprotein putative aspartyl protease [PF13975.8, score=21.9]} {RNA1509_51609} {RNA1310_3461} {RNA815_16498} | |
54. | MligTC455_32359 | 194 | 4.04 | Mlig455_054395, Mlig455_054418, Mlig455_070496 | Neo: - Age: - Region-enriched R2: 3.120/0.02401 |
STON2 | 1.731 | - | - | - | - | 0.964 | 0.767 | Mlig455_054395 {REF} {Length: 3807} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=152.1]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=5e-80]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=285, Expect=3e-82]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=374, Expect=3e-112]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=356, Expect=3e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=684, Expect=0.0]} {RNA1509_39423} {RNA1310_6760} {RNA815_11749} Mlig455_054418 {REF} {Length: 3915} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=153.1]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=3e-80]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=284, Expect=5e-82]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=374, Expect=4e-112]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=355, Expect=4e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=686, Expect=0.0]} {RNA1509_39423} {RNA1310_6760, RNA1509_39423} {RNA1509_39423, RNA815_11749} Mlig455_070496 {REF} {Length: 3566} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=76.5]} {Human: ENSG00000140022, STON2, stonin 2, [Score=178, Expect=9e-46]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [Score=182, Expect=2e-47]} {Dmel: FBgn0016975, stnB, stoned B, [Score=250, Expect=7e-70]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [Score=235, Expect=1e-64]} {Smed: dd_Smed_v6_6859_0_2, dd_Smed_v6_6859_0_2, [Score=467, Expect=5e-152]} {RNA1509_39423} {RNA1310_6760} {RNA815_11749} |
55. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 1.731 | - | - | - | 0.780 | 0.951 | - | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
56. | MligTC455_47414 | 197 | 4.09 | Mlig455_039028 | Neo: - Age: logFC(26M/2M)=-0.558 |
1.73 | - | - | - | 0.972 | - | 0.758 | Mlig455_039028 {REF} {Length: 2399} {Pfam: Integrase core domain [PF00665.28, score=45.7]} {Smed: dd_Smed_v6_94688_0_1, dd_Smed_v6_94688_0_1, [Score=58.5, Expect=4e-11]} {RNA1509_33291} {RNA1310_1940.1} {RNA815_1595} | |
57. | MligTC455_14716 | 29 | 0.61 | Mlig455_043633 | Neo: - Age: - |
ANGPTL2 | 1.727 | - | - | - | 0.777 | 0.950 | - | Mlig455_043633 {REF} {Length: 1106} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=157.6]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=134, Expect=2e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=133, Expect=4e-35]; ENSG00000085265, FCN1, ficolin 1, [Score=132, Expect=8e-36]; ENSG00000160339, FCN2, ficolin 2, [Score=128, Expect=4e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=134, Expect=1e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=119, Expect=6e-32]} {Celegans: WBGene00017013, ensh-1, [Score=57.8, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=114, Expect=1e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
58. | MligTC455_24753 | 11 | 0.23 | Mlig455_016700 | Neo: - Age: - |
1.726 | - | - | - | 0.764 | 0.962 | - | Mlig455_016700 {REF} {Length: 1032} {Pfam: PAN domain [PF00024.28, score=20.1]} {RNA1310_36328.1} {RNA815_39270} | |
59. | MligTC455_46698 | 2235 | 46.56 | Mlig455_009652 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.372/0.00045 Regeneration-depleted TP: -3.177 |
1.724 | - | - | - | - | 0.950 | 0.774 | Mlig455_009652 {REF} {Length: 763} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=33.2]; NOPS (NUC059) domain [PF08075.13, score=29.1]} {RNA1509_45891} {RNA1310_92759} {RNA815_24028} | |
60. | MligTC455_13963 | 31 | 0.64 | Mlig455_052027 | Neo: - Age: Down-Up-Down |
1.722 | - | - | - | 0.771 | 0.951 | - | Mlig455_052027 {REF} {Length: 1717} {RNA1509_48973} {RNA1310_34931} {RNA815_59614} | |
61. | MligTC455_24302 | 149 | 3.11 | Mlig455_035632 | Neo: - Age: Up-Down-Up |
KCNQ5 | 1.72 | - | - | - | 0.747 | 0.973 | - | Mlig455_035632 {REF} {Length: 2263} {Pfam: KCNQ voltage-gated potassium channel [PF03520.16, score=124.6]} {Human: ENSG00000185760, KCNQ5, potassium voltage-gated channel subfamily Q member 5, [Score=122, Expect=1e-28]; ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [Score=121, Expect=2e-28]} {Mouse: ENSMUSG00000028033, Kcnq5, potassium voltage-gated channel, subfamily Q, member 5, [Score=121, Expect=1e-28]; ENSMUSG00000028631, Kcnq4, potassium voltage-gated channel, subfamily Q, member 4, [Score=119, Expect=4e-28]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [Score=175, Expect=1e-46]} {Celegans: WBGene00002235, kqt-3, KQT-3 potassium channel; Potassium channel, KvQLT family, [Score=110, Expect=1e-25]} {Smed: dd_Smed_v6_17359_0_2, dd_Smed_v6_17359_0_2, [Score=186, Expect=2e-52]} {RNA1509_34272} {RNA1310_3730.1} {RNA815_2787} |
62. | MligTC455_18586 | 93 | 1.93 | Mlig455_020226 | Neo: - Age: Down-Down-Up |
1.718 | - | - | - | 0.760 | 0.958 | - | Mlig455_020226 {REF} {Length: 1261} {RNA1310_64121} {RNA815_32233} | |
63. | MligTC455_26765 | 686 | 14.29 | Mlig455_006971 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.201/0.00046 |
1.718 | 0.754 | - | - | - | 0.964 | - | Mlig455_006971 {REF} {Length: 6360} {Pfam: Cadherin domain [PF00028.19, score=29.2]} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [RH, Score=328, Expect=1e-93]} {RNA1509_19813, RNA1509_5311} {RNA1310_621, RNA1509_19813, RNA1509_5311} {RNA1509_19813, RNA1509_5311, RNA815_183.1} | |
64. | MligTC455_26766 | 638 | 13.3 | Mlig455_017977 | Neo: - Age: Up-Down-Down Region-specific R2: 4.360 Region-enriched R2: 3.395/0.00052 |
1.71 | 0.747 | - | - | - | 0.963 | - | Mlig455_017977 {REF} {Length: 2516} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [Score=249, Expect=3e-71]} {RNA1509_19813} {RNA1310_621} {RNA815_183.1} | |
65. | MligTC455_28693 | 60 | 1.26 | Mlig455_022354 | Neo: - Age: - |
1.695 | - | - | - | 0.740 | 0.955 | - | Mlig455_022354 {REF} {Length: 816} {Pfam: WSC domain [PF01822.21, score=53.0]; PAN domain [PF00024.28, score=20.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=48.1, Expect=2e-06]} {RNA1509_43359} {RNA1310_59466.1} {RNA815_19988} | |
66. | MligTC455_51764 | 938 | 19.55 | Mlig455_016061 | Neo: - Age: - Region-specific R2: 2.881 Region-enriched R2: 1.672/0.00180 |
1.688 | - | - | - | - | 0.968 | 0.720 | Mlig455_016061 {REF} {Length: 649} {RNA1509_58232} {RNA1310_60107.1, RNA1509_58232} {RNA1509_58232, RNA815_31573} | |
67. | MligTC455_47080 | 362 | 7.54 | Mlig455_037356 | Neo: - Age: - Region-enriched R2: 2.691/0.00566 |
SSUH2 | 1.684 | - | - | - | 0.721 | 0.963 | - | Mlig455_037356 {REF} {Length: 1984} {Pfam: DnaJ central domain [PF00684.21, score=20.9]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=156, Expect=5e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=90.9, Expect=7e-20]} {RNA1509_29510} {RNA1310_15488, RNA1509_29510} {RNA1509_29510, RNA815_5650} |
68. | MligTC455_18501 | 200 | 4.16 | Mlig455_031954 | Neo: - Age: Down-Up-Up |
1.681 | - | - | - | - | 0.965 | 0.716 | Mlig455_031954 {REF} {Length: 1030} {RNA1509_49054} {RNA1310_32906} {RNA815_15169} | |
69. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 1.671 | - | - | - | - | 0.956 | 0.715 | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
70. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
1.667 | - | - | - | - | 0.960 | 0.707 | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
71. | MligTC455_42513 | 70 | 1.45 | Mlig455_023063, Mlig455_023065 | Neo: - Age: - |
KCNC2 | 1.665 | - | - | - | - | 0.959 | 0.706 | Mlig455_023063 {REF} {Length: 2276} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.7]; Ion channel [PF07885.18, score=37.0]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=7e-87]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=280, Expect=4e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=271, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=4e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=271, Expect=3e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=285, Expect=3e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=4e-94]} {Smed: dd_Smed_v6_13250_0_2, dd_Smed_v6_13250_0_2, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} Mlig455_023065 {REF} {Length: 2276} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.7]; Ion channel [PF07885.18, score=37.0]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=7e-87]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=280, Expect=4e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=271, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=4e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=271, Expect=3e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=285, Expect=3e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=4e-94]} {Smed: dd_Smed_v6_13250_0_2, dd_Smed_v6_13250_0_2, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
72. | MligTC455_46697 | 2841 | 59.19 | Mlig455_009247 | Neo: - Age: - Region-enriched R2: 2.282/0.00076 Regeneration-downregulated BL: -2.847 Regeneration-depleted BL: -2.847 |
1.665 | - | - | - | - | 0.958 | 0.707 | Mlig455_009247 {REF} {Length: 774} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=40.0]; NOPS (NUC059) domain [PF08075.13, score=34.4]} {RNA1509_12661} {RNA1310_96333} {RNA815_24028} | |
73. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 1.665 | - | - | - | - | 0.955 | 0.710 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
74. | MligTC455_51763 | 1421 | 29.6 | Mlig455_015843 | Neo: - Age: - Region-specific R2: 3.066 Region-enriched R2: 2.560/0.00003 |
0.982 | - | - | - | - | 0.982 | - | Mlig455_015843 {REF} {Length: 805} {RNA1509_26419, RNA1509_39553, RNA1509_39658} {RNA1310_60107.2, RNA1509_26419, RNA1509_39553, RNA1509_39658} {RNA1509_26419, RNA1509_39553, RNA1509_39658, RNA815_31573} | |
75. | MligTC455_47415 | 204 | 4.25 | Mlig455_065682 | Neo: Int S/G2/M Age: - |
0.973 | - | - | - | 0.973 | - | - | Mlig455_065682 {REF} {Length: 697} {NoTransDecoderORF} {RNA1509_49419} {RNA1310_93693} {RNA815_1595} | |
76. | MligTC455_42590 | 32 | 0.67 | Mlig455_050244 | Neo: - Age: - |
GALR2 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_050244 {REF} {Length: 1946} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=169.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=40.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=33.4]; Olfactory receptor [PF13853.8, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=20.6]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=164, Expect=4e-46]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=160, Expect=6e-45]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [RH, Score=216, Expect=6e-66]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [RH, Score=208, Expect=1e-62]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=282, Expect=6e-91]} {RNA1310_75607} {RNA815_49665} |
77. | MligTC455_49593 | 323 | 6.72 | Mlig455_025219 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.432/0.00265 |
RRBP1 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_025219 {REF} {Length: 1413} {Human: ENSG00000125844, RRBP1, ribosome binding protein 1, [RH, Score=62.8, Expect=2e-11]} {RNA1509_39523} {RNA1310_52655} {RNA815_22785} |
78. | MligTC455_49594 | 855 | 17.81 | Mlig455_025640 | Neo: - Age: - Region-enriched R6: 2.500/0.02265 Regeneration-downregulated BL: -3.434 Regeneration-depleted BL: -3.434 |
RRBP1 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_025640 {REF} {Length: 981} {Human: ENSG00000125844, RRBP1, ribosome binding protein 1, [Score=57.4, Expect=9e-10]} {RNA1509_37278} {RNA1310_48523} {RNA815_22785} |
79. | MligTC455_17100 | 31 | 0.65 | Mlig455_041333 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_041333 {REF} {Length: 408} {NoTransDecoderORF} {RNA1509_7397} {RNA1310_8902} | |
80. | MligTC455_41107 | 31 | 0.64 | Mlig455_024003, Mlig455_055882 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_024003 {REF} {Length: 1460} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=47.7]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=173, Expect=1e-52]} {RNA1310_46591} Mlig455_055882 {REF} {Length: 1280} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.4]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=152, Expect=1e-44]} {RNA1310_46591} |
|
81. | MligTC455_42044 | 14 | 0.28 | Mlig455_036295 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_036295 {REF} {Length: 1775} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=32.8]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=62.8, Expect=8e-11]} {RNA1310_147392} | |
82. | MligTC455_25113 | 762 | 15.87 | Mlig455_020768 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.653/0.00004 |
0.965 | - | - | - | - | 0.965 | - | Mlig455_020768 {REF} {Length: 810} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=46.2, Expect=1e-06]} {RNA1509_36958} {RNA1310_50245} {RNA815_48543} | |
83. | MligTC455_27231 | 12 | 0.25 | Mlig455_013442 | Neo: - Age: - |
SSTR4 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_013442 {REF} {Length: 1942} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=70.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]} {Human: ENSG00000132671, SSTR4, somatostatin receptor 4, [Score=63.2, Expect=4e-10]} {Mouse: ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=72.8, Expect=2e-13]} {Dmel: FBgn0039396, CCAP-R, Crustacean cardioactive peptide receptor, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=50.8, Expect=1e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=123, Expect=1e-31]} {RNA1310_145931} |
84. | MligTC455_38049 | 11 | 0.23 | Mlig455_051337 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_051337 {REF} {Length: 2246} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=25.9]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=49.3, Expect=5e-07]} {RNA1310_57034} {RNA815_35311} | |
85. | MligTC455_39353 | 25 | 0.51 | Mlig455_042200, Mlig455_059021 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_042200 {REF} {Length: 3069} Mlig455_059021 {REF} {Length: 3095} |
|
86. | MligTC455_50505 | 454 | 9.46 | Mlig455_050904 | Neo: - Age: Down-Up-Up |
0.965 | - | - | - | - | 0.965 | - | Mlig455_050904 {REF} {Length: 1806} {RNA1509_31617} {RNA1310_16888, RNA1509_31617} {RNA1509_31617, RNA815_20985} | |
87. | MligTC455_26410 | 7 | 0.14 | Mlig455_024826 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_024826 {REF} {Length: 2174} {Pfam: SH3 domain [PF00018.30, score=28.9]; Variant SH3 domain [PF14604.8, score=22.2]; Variant SH3 domain [PF07653.19, score=22.1]} {Smed: dd_Smed_v6_8729_0_1, dd_Smed_v6_8729_0_1, [RH, Score=60.1, Expect=5e-10]} {RNA1310_32104} {RNA815_32970} | |
88. | MligTC455_28417 | 25 | 0.52 | Mlig455_059156 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_059156 {REF} {Length: 1896} {Celegans: WBGene00021498, Y40C7B.1, [Score=48.5, Expect=6e-07]} {RNA1509_5514} {RNA1310_683.1} {RNA815_1542.1} | |
89. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
0.964 | - | - | - | - | 0.964 | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
90. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
0.964 | - | - | - | - | 0.964 | - | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} | |
91. | MligTC455_19296 | 22 | 0.46 | Mlig455_007502 | Neo: - Age: - |
IRX4 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_007502 {REF} {Length: 1626} {Pfam: Homeobox KN domain [PF05920.13, score=54.1]; Homeodomain [PF00046.31, score=30.5]} {Human: ENSG00000113430, IRX4, iroquois homeobox 4, [RH, Score=149, Expect=1e-39]; ENSG00000159387, IRX6, iroquois homeobox 6, [RH, Score=145, Expect=1e-38]} {Mouse: ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [RH, Score=150, Expect=7e-40]} {Dmel: FBgn0015919, caup, caupolican, [RH, Score=153, Expect=2e-40]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [RH, Score=124, Expect=7e-32]} {Smed: dd_Smed_v6_18125_0_1, dd_Smed_v6_18125_0_1, [RH, Score=159, Expect=3e-44]} {RNA1310_58105} {RNA815_61910} |
92. | MligTC455_19297 | 22 | 0.45 | Mlig455_007400 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_007400 {REF} {Length: 228} {NoTransDecoderORF} | |
93. | MligTC455_09155 | 13 | 0.27 | Mlig455_018804, Mlig455_018976 | Neo: Irradiation Age: Up-Down-Down |
TNR | 0.962 | - | - | - | - | 0.962 | - | Mlig455_018804 {REF} {Length: 2229} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=109.9]} {Human: ENSG00000116147, TNR, tenascin R, [Score=90.1, Expect=5e-19]; ENSG00000120332, TNN, tenascin N, [Score=89.4, Expect=9e-19]; ENSG00000142748, FCN3, ficolin 3, [Score=88.6, Expect=2e-19]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=93.2, Expect=4e-20]} {Dmel: FBgn0033312, CG8642, [Score=95.1, Expect=2e-21]} {RNA1509_11866} {RNA1310_33691} {RNA815_15594.1} Mlig455_018976 {REF} {Length: 1551} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=110.1]} {Human: ENSG00000116147, TNR, tenascin R, [Score=89.7, Expect=8e-19]; ENSG00000120332, TNN, tenascin N, [Score=89.4, Expect=1e-18]; ENSG00000142748, FCN3, ficolin 3, [Score=88.2, Expect=3e-19]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=93.2, Expect=4e-20]} {Dmel: FBgn0033312, CG8642, [Score=92.4, Expect=2e-20]} {RNA1509_7554} {RNA1310_33691} {RNA815_15594.1} |
94. | MligTC455_21549 | 14 | 0.28 | Mlig455_045663 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_045663 {REF} {Length: 2100} {RNA1509_30577} {RNA1310_80313} {RNA815_55453} | |
95. | MligTC455_28626 | 89 | 1.85 | Mlig455_066175 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.805/0.00039 |
ANO7 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_066175 {REF} {Length: 4068} {TRANSSPLICED} {Pfam: Calcium-activated chloride channel [PF04547.14, score=415.9]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=105.2]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=299, Expect=3e-86]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=299, Expect=6e-87]} {Dmel: FBgn0036235, CG6938, [Score=278, Expect=1e-77]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [RH, Score=440, Expect=6e-140]} {Smed: dd_Smed_v6_4761_0_1, dd_Smed_v6_4761_0_1, [Score=312, Expect=3e-92]} {RNA1509_16739} {RNA1310_3045} {RNA815_709.1} |
96. | MligTC455_32028 | 19 | 0.39 | Mlig455_019343, Mlig455_019346 | Neo: - Age: - |
GRIA2 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_019343 {REF} {Length: 3241} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=57.9]; Receptor family ligand binding region [PF01094.30, score=49.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.0]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=1e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=146, Expect=2e-35]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=144, Expect=9e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=144, Expect=1e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=150, Expect=8e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=145, Expect=3e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=3e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=144, Expect=5e-35]} {Dmel: FBgn0039927, CG11155, [Score=158, Expect=1e-39]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=125, Expect=3e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=250, Expect=2e-75]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.1} Mlig455_019346 {REF} {Length: 519} {Pfam: Receptor family ligand binding region [PF01094.30, score=21.5]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.2} |
97. | MligTC455_42628 | 49 | 1.01 | Mlig455_004834 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_004834 {REF} {Length: 443} {NoTransDecoderORF} {RNA1310_71959.1} {RNA815_64554} | |
98. | MligTC455_43372 | 32 | 0.66 | Mlig455_024808 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_024808 {REF} {Length: 2553} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=28.5]; Prokaryotic RING finger family 4 [PF14447.8, score=25.4]} {RNA1310_52604} {RNA815_64021} | |
99. | MligTC455_44589 | 64 | 1.34 | Mlig455_006303 | Neo: - Age: - |
VAMP1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_006303 {REF} {Length: 2747} {TRANSSPLICED} {Pfam: Synaptobrevin [PF00957.23, score=111.0]} {Human: ENSG00000139190, VAMP1, vesicle associated membrane protein 1, [RH, Score=143, Expect=4e-44]; ENSG00000263620, AC129492.3, novel protein, [RH, Score=140, Expect=8e-43]; ENSG00000220205, VAMP2, vesicle associated membrane protein 2, [RH, Score=140, Expect=3e-43]} {Mouse: ENSMUSG00000020894, Vamp2, vesicle-associated membrane protein 2, [RH, Score=140, Expect=2e-43]; ENSMUSG00000030337, Vamp1, vesicle-associated membrane protein 1, [RH, Score=140, Expect=2e-43]} {Dmel: FBgn0013342, nSyb, neuronal Synaptobrevin, [RH, Score=132, Expect=6e-39]} {Celegans: WBGene00004897, snb-1, Synaptobrevin-1, [RH, Score=122, Expect=1e-36]} {Smed: dd_Smed_v6_9710_0_1, dd_Smed_v6_9710_0_1, [RH, Score=143, Expect=3e-44]} {RNA1509_16727} {RNA1310_14759} {RNA815_5228} |
100. | MligTC455_04051 | 57 | 1.18 | Mlig455_004801 | Neo: - Age: Down-Down-Down |
TIAM1 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_004801 {REF} {Length: 3193} {Pfam: RhoGEF domain [PF00621.22, score=32.1]; PDZ domain [PF17820.3, score=32.1]; PH domain [PF00169.31, score=31.3]; PDZ domain [PF00595.26, score=23.1]; PDZ domain [PF13180.8, score=22.7]; Pleckstrin homology domain [PF15410.8, score=19.6]} {Human: ENSG00000156299, TIAM1, T cell lymphoma invasion and metastasis 1, [Score=128, Expect=1e-29]; ENSG00000146426, TIAM2, T cell lymphoma invasion and metastasis 2, [Score=124, Expect=3e-28]} {Mouse: ENSMUSG00000002489, Tiam1, T cell lymphoma invasion and metastasis 1, [Score=129, Expect=3e-30]} {Dmel: FBgn0085447, sif, still life, [Score=129, Expect=4e-30]} {RNA1509_20041} {RNA1310_14754.2} {RNA815_36642} |